Sign in
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial
Journal article   Open access   Peer reviewed

Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial

Harold P Adams Jr, Enrique C Leira, James C Torner, Elliot Barnathan, Lakshmi Padgett, Mark B Effron, Werner Hacke and AbESTT-II Investigators
Stroke (1970), Vol.39(12), pp.3277-3282
12/2008
DOI: 10.1161/STROKEAHA.107.508853
PMID: 18772451
url
https://doi.org/10.1161/STROKEAHA.107.508853View
Published (Version of record) Open Access

Abstract

Comorbidity Humans Immunoglobulin Fab Fragments - adverse effects Middle Aged Stroke - diagnosis Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Male Immunoglobulin Fab Fragments - therapeutic use Cerebral Hemorrhage - diagnosis Fibrinolytic Agents - adverse effects Reperfusion Time Factors Fibrinolytic Agents - therapeutic use Aged, 80 and over Adult Female Cerebral Hemorrhage - chemically induced Double-Blind Method Hemorrhage - epidemiology Stroke - drug therapy Circadian Rhythm Immunoglobulin Fab Fragments - administration & dosage Cerebral Hemorrhage - epidemiology Antibodies, Monoclonal - administration & dosage Thrombolytic Therapy Aged Fibrinolytic Agents - administration & dosage Hemorrhage - chemically induced

Details

Logo image